Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccine

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Siegrist, Claire Anne ^a   van Delden, Christian ^a   Bel, Michael ^a   Combescure, Christophe ^a   Delhumeau, Cécile ^a   Cavassini, Matthias ^b   Clerc, Olivier ^b   Meier, Sara ^a   Hadaya, Karine ^a   Soccal, Paola M ^a   Yerly, Sabine ^a   Kaiser, Laurent ^a   Hirschel, Bernard ^a   Calmy, Alexandra ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGE; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MEMORY; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PROSPECTIVE STUDY; SEASONAL INFLUENZA; SYSTEMIC DISEASE; VIRUS STRAIN;

ADULT; AGED; ANTIBODIES, VIRAL; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC MEMORY; INFLUENZA VACCINES; INFLUENZA, HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANDEMICS;

EID: 84864411236     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040428     Document Type: Article

References (31)

1. Cordero E, Perez-Romero P, Moreno A, Len O, Montejo M, et al.((2011)) Pandemic influenza A(H1N1) virus infection in solid organ transplant recipients: impact of viral and non-viral co-infection. Clin Microbiol Infect 18:: 67--73.
2. Cordero E, Aydillo T, Farinas MC, Pano-Pardo JR, Pachon J, et al.((2011)) Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection. Eur J Clin Microbiol Infect Dis.
3. Smud A, Nagel CB, Madsen E, Rial Mdel C, Barcan LA, et al.((2010)) Pandemic influenza A/H1N1 virus infection in solid organ transplant recipients: a multicenter study. Transplantation 90:: 1458--1462.
4. Low CY, Kee T, Chan KP, Oon LL, Tan CK, et al.((2010)) Pandemic (H1N1) 2009 infection in adult solid organ transplant recipients in Singapore. Transplantation 90:: 1016--1021.
5. Kumar D, Michaels MG, Morris MI, Green M, Avery RK, et al.((2010)) Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 10:: 521--526.
6. Kunisaki KM, Janoff EN,((2009)) Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 9:: 493--504.
7. Martinez E, Marcos MA, Hoyo-Ulloa I, Anton A, Sanchez M, et al.((2011)) Influenza A H1N1 in HIV-infected adults. HIV Med 12:: 236--245.
8. Feiterna-Sperling C, Edelmann A, Nickel R, Magdorf K, Bergmann F, et al.((2010)) Pandemic influenza A (H1N1) outbreak among 15 school-aged HIV-1-infected children. Clin Infect Dis 51:: e90--94.
9. Riera M, Payeras A, Marcos MA, Viasus D, Farinas MC, et al.((2010)) Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-1-infected patients: a Spanish multicenter study. Aids 24:: 2461--2467.
10. Perez CM, Dominguez MI, Ceballos ME, Moreno C, Labarca JA, et al.((2010)) Pandemic influenza A (H1N1) in HIV-1-infected patients. Aids 24:: 2867--2869.
11. Ormsby CE, de la Rosa-Zamboni D, Vazquez-Perez J, Ablanedo-Terrazas Y, Vega-Barrientos R, et al.((2011)) Severe 2009 pandemic influenza A (H1N1) infection and increased mortality in patients with late and advanced HIV disease. Aids 25:: 435--439.
12. Hatakeyama S, Iwatsuki-Horimoto K, Okamoto K, Nukui Y, Yata N, et al.((2011)) Unadjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected adults. Vaccine 29:: 9224--9228.
13. Miraglia JL, Abdala E, Hoff PM, Luiz AM, Oliveira DS, et al.((2011)) Immunogenicity and Reactogenicity of 2009 Influenza A (H1N1) Inactivated Monovalent Non-Adjuvanted Vaccine in Elderly and Immunocompromised Patients. PLoS One 6:: e27214.
14. Lagler H, Wenisch JM, Tobudic S, Gualdoni GA, Rodler S, et al.((2011)) Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination. Vaccine 29:: 6888--6893.
15. Crespo M, Collado S, Mir M, Cao H, Barbosa F, et al.((2011)) Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patients. Clin J Am Soc Nephrol 6:: 2208--2214.
16. Launay O, Desaint C, Durier C, Loulergue P, Duval X, et al.((2011)) Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial. J Infect Dis 204:: 124--134.
17. Tremblay CL, Rouleau D, Fortin C, Toma E, Sylla M, et al.((2011)) Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients. Vaccine 29:: 1359--1363.
18. Bickel M, Wieters I, Khaykin P, Nisius G, Haberl A, et al.((2010)) Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients. Aids 24:: F31--35.
19. Manuel O, Pascual M, Hoschler K, Giulieri S, Alves D, et al.((2011)) Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients. Clin Infect Dis 52:: 248--256.
20. Calmy A, Bel M, Nguyen A, Combescure C, Delhumeau C, et al.((2011)) Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients. HIV Med.
21. Bickel M, von Hentig N, Wieters I, Khaykin P, Nisius G, et al.((2011)) Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients. Clin Infect Dis 52:: 122--127.
22. Brakemeier S, Schweiger B, Lachmann N, Glander P, Schonemann C, et al.((2011)) Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix(R)) in renal transplant recipients. Nephrol Dial Transplant.
23. Siegrist C, Ambrosioni J, Bel M, Combescure C, Hadaya K,et al. Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine. In press.
24. Cagigi A, Nilsson A, Pensieroso S, Chiodi F,((2010)) Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy. Lancet Infect Dis 10:: 499--503.
25. Titanji K, Chiodi F, Bellocco R, Schepis D, Osorio L, et al.((2005)) Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions. Aids 19:: 1947--1955.
26. Titanji K, De Milito A, Cagigi A, Thorstensson R, Grutzmeier S, et al.((2006)) Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 108:: 1580--1587.
27. L'Huillier A, Ferry T, Courvoisier D, Aebi C, Cheseaux JJ, et al.((2011)) Impaired antibody memory to varicella zoster virus in HIV-infected children: low antibody levels and avidity(*). HIV Med 13:: 54--61.
28. Crum-Cianflone NF, Iverson E, Defang G, Blair PJ, Eberly LE, et al.((2011)) Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults. Vaccine 29:: 3183--3191.
29. Gabay C, Bel M, Combescure C, Ribi C, Meier S, et al.((2011)) Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study. Arthritis Rheum 63:: 1486--1496.
30. Leroux-Roels I, Roman F, Forgus S, Maes C, De Boever F, et al.((2010)) Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. Vaccine 28:: 849--857.
31. Ho J, Moir S, Wang W, Posada JG, Gu W, et al.((2011)) Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals. Aids 25:: 295--302.